SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mikulinsky Oleg – ‘4’ for 2/27/20 re: Cryo Cell International Inc.

On:  Monday, 3/2/20, at 5:10pm ET   ·   For:  2/27/20   ·   Accession #:  899243-20-6534   ·   File #:  0-23386

Previous ‘4’:  ‘4’ on 1/13/20 for 12/3/19   ·   Next:  ‘4’ on 9/25/20 for 9/23/20   ·   Latest:  ‘4’ on 12/28/23 for 12/22/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/02/20  Mikulinsky Oleg                   4                      1:10K  Cryo Cell International Inc.      Donnelley Fin’l S… 06/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 Submission -- doc4.xml/3.6                   HTML      3K 




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Form 4 Submission
 
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Mikulinsky Oleg

(Last)(First)(Middle)
700 BROOKER CREEK BLVD, SUITE 1800

(Street)
OLDSMARFL34677

(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
CRYO CELL INTERNATIONAL INC [ CCEL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
XOfficer (give title below) Other (specify below)
Chief Information Officer
3. Date of Earliest Transaction (Month/Day/Year)
2/27/20
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock 12/3/19A 9,729 (1)A$4.1529,349D
Common Stock 12/3/19A 5,000 (1)A$8.0834,349D
Common Stock 12/23/19M 20,000A$2.0554,349D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options$6.55 2/27/20A 1,333 2/27/20 (4) 2/27/30Common Stock1,333$6.551,333D
Stock Options$3.2 4/18/16 4/18/26Common Stock40,000 40,000D
Stock Options$7.49 5/21/18 5/21/28 (2)Common Stock8,000 8,000D
Stock Option$7.13 9/4/19 9/4/29 (3)Common Stock4,444 4,444D
Explanation of Responses:
(1)  Shares of restricted stock awarded per the December 1, 2015 Employment Agreement. The shares were issued on December 3, 2019 as a result the ratification of stock issuances and equity awards at the Company's annual meeting on November 21, 2019.
(2)  1/3 on date of grant, 1/3 on December 1, 2018 and 1/3 on November 30, 2019
(3)  Stock options will vest 1/3 upon date of grant, 1/3 on December 1, 2019 and 1/3 on November 30, 2020.
(4)  Stock options will vest 1/3 upon date of grant, 1/3 on December 1, 2020 and 1/3 on November 30, 2021.
Remarks:
/s/ Oleg Mikulinsky 3/2/20
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
____________
Transaction Codes:
    A    Grant, award or other acquisition pursuant to Rule 16b-3(d).
    M    Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.

Top
Filing Submission 0000899243-20-006534   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 1:27:48.2pm ET